CYPCYNATA THERAPEUTICS LIMITEDMarket sensitive

Positive DSMB Review in Phase 1/2 Kidney Transplant Trial

Date and time: 4 December 2025 at 7:56 pm
Announcement type: Company Update

Show details

Category: Other
Report codes: 11001
Sector: Health Care
Industry group: Pharmaceuticals, Biotechnology & Life Sciences

Recent CYP announcements